Argyrophilic nucleolar organizer regions (AgNOR) of resected intrahepatic cholangiocellular carcinomas. 1995

H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

OBJECTIVE Thxe argyrophilic nucleolar organized resion (AgNOR) is loop DNA encoded for rRNA production on the nucleoli, which controls cell proliferation and protein synthesis (1,2). Based on numerous studies, it has been suggested that the AgNOR number correlates with both cellular kinetics and the malignant grade of the tumor. METHODS The argyrophilic nucleolar organized regions (AgNOR) of 14 operated cases with intrahepatic cholangiocellular carcinoma (IHCCC) were examined. RESULTS The number of AgNOR per nucleus (the AgNOR score) was found to be related to both the level of carcinoembryonic antigen (CEA) (r = 0.63, P = 0.016) and the size of the tumor (r = 0.62, P = 0.017). Regarding the age, sex, the presence or absence of lymph node metastasis, the grade of TNM classification, and the main location of the tumor, no statistical significance was recognized. On the other hand, both histological difference and differentiation were observed to remarkably reflect the AgNOR score (P = 0.03). The cancer-free survival and survival rate showed no relationship to the AgNOR score, but patients with an AgNOR number lower than 2.0 showed a poorer cancer-free survival rate as well as a poorer survival rate. Two patients with a long survival, who have been free from cancer for more than 5 years, showed a low AgNOR score (1.6, 1.7). CONCLUSIONS The AgNOR method is simple, low-cost and can easily be applied to paraffin-embedded sections. Therefore, this score is considered to be useful in identifiying malignant potentiality in intrahepatic cholangiocellular carcinoma.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009697 Nucleolus Organizer Region The chromosome region which is active in nucleolus formation and which functions in the synthesis of ribosomal RNA. Nucleolar Organizer,Nucleolar Organizers,Nucleolus Organizer Regions,Organizer Region, Nucleolus,Organizer Regions, Nucleolus,Organizer, Nucleolar,Organizers, Nucleolar,Region, Nucleolus Organizer,Regions, Nucleolus Organizer
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001650 Bile Duct Neoplasms Tumors or cancer of the BILE DUCTS. Bile Duct Cancer,Cancer of Bile Duct,Cancer of the Bile Duct,Neoplasms, Bile Duct,Bile Duct Cancers,Bile Duct Neoplasm,Cancer, Bile Duct,Cancers, Bile Duct,Neoplasm, Bile Duct

Related Publications

H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
January 1996, Tropical gastroenterology : official journal of the Digestive Diseases Foundation,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
January 2002, Journal of hepato-biliary-pancreatic surgery,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
April 2001, Pathologica,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
January 1999, Oral oncology,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
January 1994, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
January 2000, Clinical and experimental obstetrics & gynecology,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
October 1997, Japanese journal of clinical oncology,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
November 1995, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
January 1992, Nihon Geka Gakkai zasshi,
H Hayashi, and T Maeda, and E Adachi, and M Shimada, and T Matsumata, and K Takenaka
May 1994, Pathology international,
Copied contents to your clipboard!